• Stock declines 5.43% to ₹476.80 after recent up move
  • Faces rejection near ₹500 zone post results
  • Momentum cools as RSI slips from recent highs

Overview

Rossari Biotech Limited (NSE: ROSSARI) is trading near ₹476.80, down 5.43%, witnessing a decline following its latest Q4 earnings announcement. The stock had shown a recovery from lower levels recently but is now facing resistance near the ₹500 mark.

The current move reflects a pause after the rebound, with price reacting to the upper supply zone.

Fundamental View

For the quarter ended March 2026, the company reported total income of ₹53,886.70 lakh. Profit before tax stood at ₹7,354.60 lakh, while net profit came in at ₹5,473.00 lakh. Earnings per share was ₹9.88.

The earnings indicate stable operational performance, but the recent price behaviour suggests the market had already priced in near-term positives.

Technical View

Technically, Rossari Biotech Limited is trading near ₹476.80 and remains close to its 50-day SMA around ₹468.54, indicating a neutral-to-stabilising structure.

Price action shows a rebound from recent lows followed by rejection near ₹500, forming a short-term resistance zone. The latest decline suggests consolidation within a broader recovery attempt rather than a breakdown.

The 14-day RSI is near 51.26 and trending lower, indicating easing momentum after the recent upswing.

Key Technical Levels

Immediate support is placed at ₹435–₹410, which may act as a cushion if selling pressure continues.

On the upside, resistance is seen at ₹502–₹545, where supply has recently emerged.

Source: TradingView

Risks To Watch

• Rejection near ₹500 resistance band
  • Momentum cooling after short-term rally
  • Volatility around earnings reaction
  • Failure to hold above 50-day average

Summary

Rossari Biotech Limited has seen a post-results pullback after attempting a recovery. While the broader structure is stabilising near key averages, the near-term setup suggests consolidation.

Holding above ₹435 will be important, while a move above ₹502 is needed for further upside traction.

FAQs

Why did Rossari Biotech stock fall today?
The decline follows resistance near ₹500 and a post-earnings reaction after a recent rebound.

Is the trend turning negative?
Not yet—price is still near key averages, suggesting consolidation rather than reversal.

What levels should be tracked?
Support at ₹435–₹410 and resistance at ₹502–₹545.